+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endometrial Ablation Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

  • PDF Icon

    Report

  • June 2021
  • Region: Global
  • GlobalData
  • ID: 5134607
Endometrial Ablation Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within General Surgery therapeutic area.

The model discusses in detail the impact of COVID-19 on Endometrial Ablation Devices market for the year 2020 and beyond. Endometrial Ablation Devices are used for treatment of Abnormal Menstrual Bleeding (Mennorhagia ). Endometrial Ablation Device is used for the removal of a portion of endometrial layer of the uterus and the endometrial layer is still functional but significant reduction in menstrual blood is observed. The procedure involved is Hysterectomy surgery for 1st generation technique whereas for 2nd generation techniques hysteroscope is not required.

Endometrial Ablation is generally performed in premenopausal women with High Menstrual Bleeding (HMB) and those who have completed child bearing and women with normal uterine or having small uterine fibroids of size less than 3 cm in diameter. In women with HMB alone and pregnancy of 10 months endometrial ablation is preferred by the use of hysteroscope. There are varying modalities in which endometrial ablation can be performed including surgical energy (RF, Microwave, Cryoablation) or standalone techniques such as thermal balloon ablation.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Endometrial Ablation Devices and evolving competitive landscape -
  • Insightful review of the key industry trends.
  • Annualized total Endometrial Ablation Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total installed bases, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, the publisher analysts provide unique country specific insights on the market.
  • SWOT analysis for Endometrial Ablation Devices market.
  • Competitive dynamics insights and trends provided for Endometrial Ablation Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Ethicon Inc, CooperSurgical Inc, Minerva Surgical Inc, Hologic Inc, Veldana Medical SA, IDOMAN-MED, Omnitech Systems Inc, Channel Medsystems, Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
  • CMO executives who must have deep understanding of the Endometrial Ablation Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -
  • Understand the impact of COVID-19 on Endometrial Ablation Devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Endometrial Ablation Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endometrial Ablation Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Endometrial Ablation Devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ethicon Inc
  • CooperSurgical Inc
  • Minerva Surgical Inc
  • Hologic Inc
  • Veldana Medical SA
  • IDOMAN-MED
  • Omnitech Systems Inc
  • Channel Medsystems